Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery
about
Proinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic classIncreased contractile response to 5-hydroxytryptamine1-receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergyVascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized ratThe effect of fenfluramine on the pulmonary disposition of 5-hydroxytryptamine in the isolated perfused rat lung: a comparison with chlorphentermineProliferation and signaling in fibroblasts: role of 5-hydroxytryptamine2A receptor and transporterCardiovascular tolerability and safety of triptans: a review of clinical data.5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies.The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation.Triptans and chest symptoms: the role of pulmonary vasoconstriction.Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.Pulmonary arterial hypertension: new insights and new hope.The contraction of smooth muscle cells of intrapulmonary arterioles is determined by the frequency of Ca2+ oscillations induced by 5-HT and KClPulmonary hypertension and the serotonin hypothesis: where are we now?Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblastsPulmonary hypertension: therapeutic targets within the serotonin system.Acute migraine in the Emergency Department: extending European principles of management.Anticipated classes of new medications and molecular targets for pulmonary arterial hypertensionRole of the serotonin transporter in pulmonary arterial hypertension.Lung Circulation.5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor5-HT moduline: an endogenous inhibitor of 5-HT(1B/1D)-mediated contraction in pulmonary arteries.5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries.Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels.Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid function.Cardiovascular safety of triptans.The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions.5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice.The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series).
P2860
Q28292548-BFA46221-0CFA-4F43-BEF3-D5A57BFFBAD6Q28361077-18082874-58C6-4D7D-B473-F0A979677235Q28365866-182DF553-C4BD-42E7-AF3E-EDB1C0C09E06Q28373184-89118EFD-A357-4E44-B7B5-8301F6AAC743Q28584165-86011A13-32D4-4B2A-95F8-B5CC8BA660ABQ30932202-FC60021B-697B-4866-99E5-7CA3E8A99839Q34035781-1BC5D9BE-B378-4DEF-B5F8-82B7645EC1BEQ34481198-82C1538C-C2A5-4C5A-BA6A-8BB417041558Q35026918-4AAE1D94-B32F-4935-8F15-87D2B827224BQ35117079-C1BAE2A3-729D-4CA9-83CC-B53AA44EFC2FQ35696691-25180678-09B4-4DA8-BB23-041CBFF1081EQ35775292-8ED09819-5996-4638-8780-CC500D5C3A90Q36291045-00BF8AD0-D4B7-4A91-A1F7-D568ED97EC0BQ36372605-059F87BC-C2D9-46B2-8914-DFA9C7A86E4BQ36445967-6D481FC0-3AAF-464D-99AF-4FEF27A17507Q36896642-3E5849AC-621B-4B09-ACDD-E59E58792E5BQ36964956-57BFFA28-135D-485D-99AD-989249A48AD4Q37184405-9F7FA145-2C49-42F2-8F8E-775AA1B35DFDQ37266261-05D26CE6-CCFD-4653-82CD-F6DD93CCF591Q38105550-FDF2DFCE-DC3B-4DC7-B5D5-6A89D3FE5E12Q38177356-D235E64B-9550-4E40-A0E9-080E32424E5DQ38804579-0FB9B0A5-309E-4685-8792-D375BDB67E85Q41824586-163BCF11-5870-44AF-99E1-E1DD1BD6393FQ41972338-23B86C79-5B9B-4052-8FC3-1F58C3B994BAQ41992844-A4553F44-BD92-423C-B226-0250517A4347Q42538062-2FFFDB42-883C-4F1A-9466-38E5CB5B62E1Q43678620-D6D68A56-906B-4CE8-8250-569558E2F933Q44793025-EB7F2D67-67F4-4C6A-8A8D-5384BC8E3DEEQ44935645-9982A98E-D2DA-4CA8-8CBD-C5023B7AF1E4Q46808851-3DE8D449-9192-4235-BE09-5C83CECF1F88Q46954874-9A8A657F-6D54-4171-9494-431797DAAAC8Q49975788-F18DF5DB-0E0C-468F-BB81-79CD1C4052F0Q55394065-517364FE-D747-4508-AB99-430261500531
P2860
Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery
@en
Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery
@nl
type
label
Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery
@en
Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery
@nl
prefLabel
Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery
@en
Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery
@nl
P2093
P2860
P1476
Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery
@en
P2093
A G Templeton
I Morecroft
M R MacLean
R A Clayton
P2860
P304
P356
10.1111/J.1476-5381.1996.TB15982.X
P407
P577
1996-09-01T00:00:00Z